Fisiopatología e Historia Natural de las Enfermedades Hepáticas y Gastroenterológicas

Llovet, LP; Gratacos-Gines, J; Tellez, L; Gomez-Outomuro, A; Navascues, CA; Riveiro-Barciela, M; Vinuesa, R; Gomez-Camarero, J; Garcia-Retortillo, M; Diaz-Fontenla, F; Salcedo, M; Garcia-Eliz, M; Horta, D; Guerrero, M; Rodriguez-Peralvarez, M; Fernandez-Rodriguez, C; Albillos, A; G-Abraldes, J; Pares, A; Londono, MC.

Noninvasive Prediction of Outcomes in Autoimmune Hepatitis-Related Cirrhosis

Hepatology Communications. 2022; 6(6): 1392-1402 Nº de citas: 13 [doi:10.1002/hep4.1889]

Caballero-Marcos, A; Citores, MJ; Alonso-Fernandez, R; Rodriguez-Peralvarez, M; Valerio, M; Morales, JG; Cuervas-Mons, V; Cachero, A; Loinaz-Segurola, C; Inarrairaegui, M; Castells, L; Pascual, S; Vinaixa-Aunes, C; Gonzalez-Grande, R; Otero, A; Tome, S; Tejedor-Tejada, J; Fernandez-Yunquera, A; Gonzalez-Dieguez, L; Nogueras-Lopez, F; Blanco-Fernandez, G; Diaz-Fontenla, F; Bustamante, FJ; Romero-Cristobal, M; Martin-Mateos, R; Arias-Milla, A; Calatayud, L; Marcacuzco-Quinto, AA; Fernandez-Alonso, V; Gomez-Gavara, C; Munoz, P; Banares, R; Pons, JA; Salcedo, M.

Decreased Long-Term Severe Acute Respiratory Syndrome Coronavirus 2-Specific Humoral Immunity in Liver Transplantation Recipients 12 Months After Coronavirus Disease 2019

LIVER TRANSPLANTATION. 2022; 28(6): 1039-1050 Nº de citas: 8 [doi:10.1002/lt.26389]

Serrano, MT; Sabroso, S; Esteban, LM; Berenguer, M; Fondevila, C; Lorente, S; Cortes, L; Sanchez-Antolin, G; Nuno, J; de la Rosa, G; Salcedo, M; Registry.

Mortality and Causes of Death After Liver Transplantation: Analysis of Sex Differences in a Large Nationwide Cohort

TRANSPLANT INTERNATIONAL. 2022; 35: Nº de citas: 53 [doi:10.3389/ti.2022.10263]

Rodriguez-Agudo, R; Goikoetxea-Usandizaga, N; Serrano-Macia, M; Fernandez-Tussy, P; Fernandez-Ramos, D; Lachiondo-Ortega, S; Gonzalez-Recio, I; Gil-Pitarch, C; Mercado-Gomez, M; Moran, L; Bizkarguenaga, M; Lopitz-Otsoa, F; Petrov, P; Bravo, M; Van Liempd, SM; Falcon-Perez, JM; Zabala-Letona, A; Carracedo, A; Castell, JV; Jover, R; Martinez-Cruz, LA; Delgado, TC; Cubero, FJ; Lucena, MI; Andrade, RJ; Mabe, J; Simon, J; Martinez-Chantar, ML.

Methionine Cycle Rewiring by Targeting miR-873-5p Modulates Ammonia Metabolism to Protect the Liver from Acetaminophen

Antioxidants. 2022; 11(5): Nº de citas: 7 [doi:10.3390/antiox11050897]

Turnes, J; Rincon, D; Calleja, JL; Delgado, MB; Rosales, JM; Andrade, RJ; Manzano, ML; Salmeron, FJ; Calvo, M; Gomez, J; Molina, E; Frias, YN; Galvez-Fernandez, RM; Vallejo-Senra, N; Paris, S; Lamadrid, RSD; Olveira, A.

Non-pharmacologic direct cost of a simplified strategy with glecaprevir/pibrentasvir for 8 weeks in naive non-cirrhotic patients with hepatitis C implemented in clinical practice. The Just SIMPLE Study

Gastroenterologia y Hepatologia. 2022; 45(5): 342-349 Nº de citas: 2 [doi:10.1016/j.gastrohep.2021.05.015]

Semmler, G; Meyer, EL; Kozbial, K; Schwabl, P; Hametner-Schreil, S; Zanetto, A; Bauer, D; Chromy, D; Simbrunner, B; Scheiner, B; Stattermayer, AF; Pinter, M; Schofl, R; Russo, FP; Greenfield, H; Schwarz, M; Schwarz, C; Gschwantler, M; Lopez, SA; Manzano, ML; Ahumada, A; Banares, R; Pons, M; Rodriguez-Tajes, S; Genesca, J; Lens, S; Trauner, M; Ferenci, P; Reiberger, T; Mandorfer, M.

HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease

JOURNAL OF HEPATOLOGY. 2022; 76(4): 812-821 Nº de citas: 119 [doi:10.1016/j.jhep.2021.11.025]

Feakins, R; Torres, J; Borralho-Nunes, P; Burisch, J; Goncalves, TC; De Ridder, L; Driessen, A; Lobaton, T; Menchen, L; Mookhoek, A; Noor, N; Svrcek, M; Villanacci, V; Zidar, N; Tripathi, M.

ECCO Topical Review on Clinicopathological Spectrum and Differential Diagnosis of Inflammatory Bowel Disease

Journal of Crohns & Colitis. 2022; 16(3): 343-368 Nº de citas: 37 [doi:10.1093/ecco-jcc/jjab141]

Martin-Hernandez, D; Gutierrez, IL; Gonzalez-Prieto, M; MacDowell, KS; Robledo-Montana, J; Tendilla-Beltran, H; Calleja-Rodriguez, N; Bris, AG; Ulecia-Moron, C; Moreno, B; Caso, JR; Garcia-Bueno, B; Rodrigues-Mascarenhas, S; Marin-Jimenez, I; Leza, JC; Menchen, L.

Sphk2 deletion is involved in structural abnormalities and Th17 response but does not aggravate colon inflammation induced by sub-chronic stress

Scientific Reports. 2022; 12(1): Nº de citas: 5 [doi:10.1038/s41598-022-08011-8]

Marín-Jiménez I; Acosta MB; Esteve M; Castro-Laria L; García-López S; Ceballos D; Echarri A; Martín-Arranz MD; Busquets D; Llaó J; Navarro-Llavat M; Huguet JM; Argüelles-Arias F; Vicente R; Boudet JM; Díaz G; Sánchez-Migallón AM; Casellas F; for RAPIDA trial investigators.

Rapidity of clinical response to adalimumab and improvement of quality of life in luminal Crohn's disease: RAPIDA study

Gastroenterologia y Hepatologia. 2022; 45(3): 165-176 Nº de citas: 5 [doi:10.1016/j.gastrohep.2021.04.010]

Guijarro, LG; Cano-Martinez, D; Toledo-Lobo, MV; Ruiz-Llorente, L; Chaparro, M; Guerra, I; Iborra, M; Cabriada, JL; Bujanda, L; Taxonera, C; Garcia-Sanchez, V; Marin-Jimenez, I; Barreiro-de Acosta, M; Vera, I; Martin-Arranz, MD; Mesonero, F; Sempere, L; Gomollon, F; Hinojosa, J; Zoullas, S; Monserrat, J; Menor-Salvan, C; Alvarez-Mon, M; Gisbert, JP; Ortega, MA; Hernandez-Breijo, B; GETECCU.

Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn's Disease Severity

Biomedicines. 2022; 10(3): Nº de citas: 9 [doi:10.3390/biomedicines10030727]

Virseda-Berdices, A; Brochado-Kith, O; Diez, C; Hontanon, V; Berenguer, J; Gonzalez-Garcia, J; Rojo, D; Fernandez-Rodriguez, A; Ibanez-Samaniego, L; Llop-Herrera, E; Olveira, A; Perez-Latorre, L; Barbas, C; Rava, M; Resino, S; Jimenez-Sousa, MA.

Blood microbiome is associated with changes in portal hypertension after successful direct-acting antiviral therapy in patients with HCV-related cirrhosis

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2022; 77(3): 719-726 Nº de citas: 12 [doi:10.1093/jac/dkab444]

Ye, H; Chen, CB; Wu, HH; Zheng, K; Martin-Adrados, B; Caparros, E; Frances, R; Nelson, LJ; del Moral, MG; Asensio, I; Vaquero, J; Banares, R; Avila, MA; Andrade, RJ; Lucena, MI; Martinez-Chantar, ML; Reeves, HL; Masson, S; Blumberg, RS; Gracia-Sancho, J; Nevzorova, YA; Martinez-Naves, E; Cubero, FJ.

Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy

Cell Death & Disease. 2022; 13(2): Nº de citas: 26 [doi:10.1038/s41419-022-04580-8]

Morales-Arraez, D; Ventura-Cots, M; Altamirano, J; Abraldes, JG; Cruz-Lemini, M; Thursz, MR; Atkinson, SR; Sarin, SK; Kim, W; Chavez-Araujo, R; Higuera-de La Tijera, MF; Singal, AK; Shah, VH; Kamath, PS; Duarte-Rojo, A; Charles, EA; Vargas, V; Jager, M; Rautou, PE; Rincon, D; Zamarripa, F; Restrepo-Gutierrez, JC; Torre, A; Lucey, MR; Arab, JP; Mathurin, P; Louvet, A; Garcia-Tsao, G; Gonzalez, JA; Verna, EC; Brown, RS; Argemi, J; Fernandez-Carillo, C; Clemente, A; Alvarado-Tapias, E; Forrest, E; Allison, M; Bataller, R.

The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study

AMERICAN JOURNAL OF GASTROENTEROLOGY. 2022; 117(2): 301-310 Nº de citas: 75 [doi:10.14309/ajg.0000000000001596]

Gutierrez, A; Zapater, P; Ricart, E; Gonzalez-Vivo, M; Gordillo, J; Olivares, D; Vera, I; Manosa, M; Gisbert, JP; Aguas, M; Sanchez-Rodriguez, E; Bosca-Watts, M; Laredo, V; Camps, B; Marin-Jimenez, I; Zabana, Y; Martin-Arranz, MD; Munoz, R; Navarro, M; Sierra, E; Madero, L; Vela, M; Perez-Calle, JL; Sainz, E; Calvet, X; Arias, L; Morales, V; Bermejo, F; Fernandez-Salazar, L; Van Domselaar, M; De Castro, L; Rodriguez, C; Munoz-Villafranca, C; Lorente, R; Rivero, M; Iglesias, E; Herreros, B; Busquets, D; Riera, J; Martinez-Montiel, MP; Roldon, M; Roncero, O; Hinojosa, E; Sierra, M; Barrio, J; De Francisco, R; Huguet, J; Merino, O; Carpio, D; Ginard, D; Munoz, F; Marta, P; Almela, P; Argueelles-Arias, F; Alcain, G; Luis, B; Mancenido, N; Lucendo, AJ; Varela, P; Rodriguez-Lago, I; Ramos, L; Laura, S; Sese, E; Acosta, MBD; Domenech, E; Frances, R; ENEIDA Project of GETECCU.

Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients

Frontiers in Medicine. 2022; 9: Nº de citas: 7 [doi:10.3389/fmed.2022.823900]

Manka, P; Sydor, S; Schanzer-Ocklenburg, JM; Brandenburg, M; Best, J; Vilchez-Vargas, R; Link, A; Heider, D; Brodesser, S; Figge, A; Jahnert, A; Coombes, JD; Cubero, FJ; Kahraman, A; Kim, MS; Kalsch, J; Kinner, S; Faber, KN; Moshage, H; Gerken, G; Syn, WK; Canbay, A; Bechmann, LP.

A Potential Role for Bile Acid Signaling in Celiac Disease-Associated Fatty Liver

Metabolites. 2022; 12(2): Nº de citas: 6 [doi:10.3390/metabo12020130]

Ibanez-Samaniego, L; Rapado-Castro, M; Cabrero, L; Navarrete, C; Garcia-Mulas, S; Ahumada, A; Marquez, L; Perez, MD; Rincon, D; Banares, R; Garcia-Martinez, R.

Hepatitis C eradication improves cognitive function in patients with or without cirrhosis: A prospective real-life study

EUROPEAN JOURNAL OF NEUROLOGY. 2022; 29(2): 400-412 Nº de citas: 15 [doi:10.1111/ene.15138]

Guo, FF; Estevez-Vazquez, O; Benede-Ubieto, R; Maya-Miles, D; Zheng, K; Gallego-Duran, R; Rojas, A; Ampuero, J; Romero-Gomez, M; Philip, K; Egbuniwe, IU; Chen, CB; Simon, J; Delgado, TC; Martinez-Chantar, ML; Sun, J; Reissing, J; Bruns, T; Lamas-Paz, A; del Moral, MG; Woitok, MM; Vaquero, J; Regueiro, JR; Liedtke, C; Trautwein, C; Banares, R; Cubero, FJ; Nevzorova, YA.

A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized Therapy

Cancers. 2022; 14(1): Nº de citas: 16 [doi:10.3390/cancers14010192]

Gomez-Bravo, MA; Prieto, M; Navasa, M; Sanchez-Antolin, G; Llado, L; Otero, A; Serrano, T; Jimenez-Romero, C; Garcia-Gonzalez, M; Valdivieso, A; Gonzalez-Dieguez, ML; de la Mata, M; Pons, JA; Salcedo, M; Rodrigo, JM; Cuervas-Mons, V; Gonzalez, A; Caralt, M; Pardo, F; Varo, E; Crespo, G; Rubin, A; Guilera, M; Aldea, A; Santoyo, J.

Effects of everolimus plus minimized tacrolimus on kidney function in liver transplantation: REDUCE, a prospective, randomized controlled study

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS. 2022; 114(6): 335-342 Nº de citas: 7 [doi:10.17235/reed.2022.8549/2021]